DeuteRx
David Simcox is currently an R&D Advisor at DeuteRx. Previously, they were on the Board of Directors for the Commercial Development and Marketing Association from 2006 to 2009. Before that, they were with FMC Corp as the Director of Health Care Ventures from 1998 to 2006. David Simcox has dedicated their career to helping businesses grow and develop products in a variety of industries.
David Simcox completed their BS in Biochemistry at the University of Illinois Urbana-Champaign. David then completed their PhD in Biochemistry at the University of California, Los Angeles. After completing their PhD, they worked as a post-doc in Plant Biochemistry at Queen's University.
This person is not in the org chart
This person is not in any offices
DeuteRx
Formed in 2012, DeuteRx is a virtual biopharmaceutical company focused on improving racemic drugs for patients. The team has pioneered the use of Deuterium-Enabled Chiral Switching (DECS) to isolate a single stereoisomer from a mixture of interconverting stereoisomers.